Lilly Data Show Zepbound Reduces Type 2 Diabetes Risk Long Term

 
• By Joseph Haas
  
Preventive medicine
Lilly reports data showing a diabetes prevention benefit with tirzepatide • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D